Literature DB >> 18688656

Waiting for combined treatment with RAS inhibitors in children with primary glomerulonephritis.

Marco Zaffanello.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688656     DOI: 10.1007/s00467-008-0936-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  9 in total

Review 1.  Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

Authors:  Martin MacKinnon; Sabin Shurraw; Ayub Akbari; Greg A Knoll; James Jaffey; Heather D Clark
Journal:  Am J Kidney Dis       Date:  2006-07       Impact factor: 8.860

2.  Candesartan cilexetil in children with hypertension or proteinuria: preliminary data.

Authors:  Giacomo D Simonetti; Rodo O von Vigier; Martin Konrad; Mattia Rizzi; Emilio Fossali; Mario G Bianchetti
Journal:  Pediatr Nephrol       Date:  2006-06-27       Impact factor: 3.714

3.  Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors.

Authors:  Mieczysław Litwin; Ryszard Grenda; Joanna Sladowska; Jolanta Antoniewicz
Journal:  Pediatr Nephrol       Date:  2006-08-15       Impact factor: 3.714

Review 4.  New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.

Authors:  Marco Zaffanello; Massimo Franchini; Vassilios Fanos
Journal:  Pharmacotherapy       Date:  2008-01       Impact factor: 4.705

Review 5.  Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome?

Authors:  Fábio Fernandes Borges; Luciana Shiraichi; Marcos Paulo Hippólito da Silva; Eduardo Isaac Nishimoto; Paulo Cesar Koch Nogueira
Journal:  Pediatr Nephrol       Date:  2007-06-06       Impact factor: 3.714

6.  IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.

Authors:  Rosanna Coppo; Licia Peruzzi; Alessandro Amore; Antonio Piccoli; Pierre Cochat; Rosario Stone; Martin Kirschstein; Tommy Linné
Journal:  J Am Soc Nephrol       Date:  2007-05-18       Impact factor: 10.121

7.  Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.

Authors:  Fausta Catapano; Paolo Chiodini; Luca De Nicola; Roberto Minutolo; Pasquale Zamboli; Ciro Gallo; Giuseppe Conte
Journal:  Am J Kidney Dis       Date:  2008-05-12       Impact factor: 8.860

Review 8.  Slowing chronic kidney disease progression: results of prospective clinical trials in adults.

Authors:  Thai Nguyen; Robert D Toto
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

Review 9.  Therapeutic strategies to slow chronic kidney disease progression.

Authors:  Elke Wühl; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2008-03-12       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.